TNFRSF25 Antibody (YA4413)

(Synonyms: DR3; TR3; DDR3; LARD; APO-3; TRAMP; WSL-1; GEF720; WSL-LR; PLEKHG5; TNFRSF12)
Customer Review

Based on 1 Customer Validation

TNFRSF25 Antibody (YA4413) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TNFRSF25.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG1

  • Application:

    IHC-P, FC, ELISA

  • Reactivity :

    Human

  • Formulation:

    Supplied in PBS with 0.05% sodium azide

  • Conjugation:
    Non-conjugated

Applications

Application
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
FC Info
FC: Flow Cytometry
ELISA Info
ELISA: Enzyme Linked Immunosorbent Assay
Dilution Ratio 1:200-1:1000 1:200-1:400 1:10000

Product Details

Description

TNFRSF25 Antibody (YA4413) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to TNFRSF25.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
  • Calculated Molecular Weight Predicted band size: 45.4 kDa
Immunogen

Purified recombinant fragment of human TNFRSF25 (AA: extra(25-199)) expressed in E. Coli.

Purification

affinity purified.

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG1

RRID

AB_3718968

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in PBS with 0.05% sodium azide

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Verification Images

  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Gastric Cancer tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Cervical cancer tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Cervical cancer tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Tonsil tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Tonsil tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
  • Experimental Validation Results for TNFRSF25 Antibody (YA4413)
    Immunohistochemical analysis of paraffin-embedded human Tonsil tissue using TNFRSF25 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P84716, 1:600 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.

Background

  • Function

    TNFRSF25 receptor for TNFSF12/APO3L/TWEAK. Interacts directly with the adapter TRADD. Mediates activation of NF-kappa-B and induces apoptosis. May play a role in regulating lymphocyte homeostasis

  • Subcellular Localization

    Cell membrane; Single-pass type I membrane protein; Cell membrane; Single-pass type I membrane protein; Cell membrane; Single-pass type I membrane protein; Cell membrane; Single-pass type I membrane protein; Secreted; Secreted; Secreted; Secreted; Secreted; Secreted; Secreted; Secreted

  • Expression


    Tissue_specificity:Abundantly expressed in thymocytes and lymphocytes. Detected in lymphocyte-rich tissues such as thymus, colon, intestine, and spleen. Also found in the prostate

  • Isoforms & Post-Translational Modification

    Q93038 has 12 isomers: Q93038-1: 45385 Da (predicted); Q93038-2: 45456 Da (predicted); Q93038-3: 23198 Da (predicted); Q93038-4: 27004 Da (predicted); Q93038-5: 19432 Da (predicted); Q93038-6: 14439 Da (predicted); Q93038-7: 13349 Da (predicted); Q93038-8: 25373 Da (predicted); Q93038-9: 40391 Da (predicted); Q93038-10: 41193 Da (predicted); Q93038-11: 45928 Da (predicted); Q93038-12: 29111 Da (predicted).
    (Microbial infection) Glycosylated at Arg-352 by enteropathogenic E.coli protein NleB1;Glycosylated

  • Subunit

    Homodimer. Interacts strongly via the death domains with TNFRSF1 and TRADD to activate at least two distinct signaling cascades, apoptosis and NF-kappa-B signaling. Interacts with BAG4

  • SwissProt ID

    Q93038

  • Gene ID
  • Synonyms

    DR3; TR3; DDR3; LARD; APO-3; TRAMP; WSL-1; GEF720; WSL-LR; PLEKHG5; TNFRSF12

TNFRSF25 Antibody (YA4413) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00